Table 2.
Changes in plasma lipids and CRP from baseline in the total population at 6 months.
| Outcome | Group | Difference (95% CI) | % change | p value |
|---|---|---|---|---|
| TC (mmol/L) | Between | 0.016 (−0.15, 0.18) | 0.29 | 0.8480 |
| Active | −0.009 (−0.12, 0.11) | −0.17 | 0.8809 | |
| Placebo | −0.025 (−0.14, 0.09) | −0.46 | 0.6738 | |
| HDL-C (mmol/L) | Between | −0.014 (−0.70, 0.04) | −0.99 | 0.6350 |
| Active | 0.005 (−0.03, 0.04) | 0.36 | 0.8094 | |
| Placebo | 0.018 (−0.02, 0.06) | 1.35 | 0.3614 | |
| LDL-C (mmol/L) | Between | −0.002 (−0.13, 0.13) | 0.00 | 0.9806 |
| Active | 0.087 (−0.01, 0.18) | 2.70 | 0.0667 | |
| Placebo | 0.088 (0.00, 0.18) | 2.70 | 0.0618 | |
| TG (mmol/L) | Between | 0.153 (−0.10, 0.41) | 8.69 | 0.2393 |
| Active | 0.020 (−0.16, 0.20) | 1.36 | 0.8326 | |
| Placebo | −0.132 (−0.31, 0.05) | −7.33 | 0.1480 | |
| CRP (mg/L) | Between | −0.283 (−1.37, 0.81) | −7.35 | 0.6092 |
| Active | −0.199 (−0.97, 0.57) | −4.67 | 0.6100 | |
| Placebo | 0.084 (−0.68, 0.85) | 2.68 | 0.8302 |
Data is presented as mean change (110 participants per group) with 95% CIs and p values calculated using a GLM. CI, confidence interval; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol, TG, triglycerides; CRP, C-reactive protein.